288 related articles for article (PubMed ID: 30909080)
41. Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial-Mesenchymal Transition.
Deng Y; Wan Q; Yan W
Cancer Manag Res; 2019; 11():9609-9620. PubMed ID: 32009816
[TBL] [Abstract][Full Text] [Related]
42. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
[TBL] [Abstract][Full Text] [Related]
43. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
[TBL] [Abstract][Full Text] [Related]
44. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Yamamoto T
J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
[TBL] [Abstract][Full Text] [Related]
45. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
46. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
47. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
Smolensky D; Rathore K; Bourn J; Cekanova M
J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518
[TBL] [Abstract][Full Text] [Related]
50. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
51. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
Wei M; Wu Y; Liu H; Xie C
Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
[TBL] [Abstract][Full Text] [Related]
52. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
[TBL] [Abstract][Full Text] [Related]
53. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
54. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway.
Wei J; Wu J; Xu W; Nie H; Zhou R; Wang R; Liu Y; Tang G; Wu J
Cell Death Dis; 2018 May; 9(6):599. PubMed ID: 29789538
[TBL] [Abstract][Full Text] [Related]
55. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
He W; Lai R; Lin Q; Huang Y; Wang L
J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
[TBL] [Abstract][Full Text] [Related]
56. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
57. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
Pan LN; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
[TBL] [Abstract][Full Text] [Related]
58. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.
Tang G; Tang Q; Jia L; Chen Y; Lin L; Kuai X; Gong A; Feng Z
Int J Mol Med; 2019 Dec; 44(6):2161-2170. PubMed ID: 31638186
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
[TBL] [Abstract][Full Text] [Related]
60. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a.
Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S
Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
